Cabergoline Tablet
Product Images NDC 70069-824

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cabergoline (NDC 70069-824). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Somerset Therapeutics, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (999ea838 E592 4769 A702 68d934de3e1d 02)

Chemical structure of the active ingredient cabergoline, showing the molecular arrangement with labeled chemical bonds and nitrogen, oxygen, carbon, and hydrogen atoms.*

FDA Label Image

Image (999ea838 E592 4769 A702 68d934de3e1d 03)

Label for Cabergoline Tablets USP 0.5 mg oral tablets by Somerset Therapeutics, LLC. The label indicates a package containing 8 tablets. It includes storage instructions, a barcode, manufacturer details, and a reserved unvarnished area. The label also notes prescription use and references accompanying dosing information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.